Molina Healthcare, Inc (NYSE:MOH) Given Consensus Rating of “Hold” by Brokerages

Shares of Molina Healthcare, Inc (NYSE:MOH) have received an average rating of “Hold” from the seventeen analysts that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, thirteen have given a hold rating and three have given a buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $184.8125.

Several analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $129.00 target price on shares of Molina Healthcare in a research report on Friday, April 24th. Weiss Ratings raised Molina Healthcare from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, June 25th. Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective for the company in a research note on Wednesday, April 29th. Zacks Research upgraded Molina Healthcare from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Molina Healthcare in a research note on Friday, March 13th.

Molina Healthcare Stock Performance

Molina Healthcare stock opened at $229.19 on Monday. Molina Healthcare has a fifty-two week low of $121.06 and a fifty-two week high of $242.56. The firm’s 50 day simple moving average is $194.39 and its 200-day simple moving average is $170.71. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The company has a market cap of $11.94 billion, a P/E ratio of 67.81 and a beta of 0.74.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. During the same quarter last year, the business posted $6.08 EPS. The company’s revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, equities research analysts predict that Molina Healthcare will post 5.23 EPS for the current year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares in the company, valued at $2,454,713.25. This represents a 4.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 1.44% of the company’s stock.

Hedge Funds Weigh In On Molina Healthcare

A number of hedge funds have recently modified their holdings of the stock. 7G Capital Management LLC acquired a new position in Molina Healthcare during the fourth quarter worth $1,735,000. BNP Paribas Financial Markets raised its holdings in Molina Healthcare by 63.0% during the fourth quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company’s stock valued at $76,248,000 after buying an additional 169,739 shares in the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Molina Healthcare by 241.2% in the fourth quarter. Assenagon Asset Management S.A. now owns 271,224 shares of the company’s stock worth $47,068,000 after buying an additional 191,731 shares during the last quarter. Victory Capital Management Inc. boosted its stake in shares of Molina Healthcare by 344.3% during the 3rd quarter. Victory Capital Management Inc. now owns 963,526 shares of the company’s stock worth $184,380,000 after acquiring an additional 746,639 shares in the last quarter. Finally, Royce & Associates LP boosted its stake in shares of Molina Healthcare by 31.1% during the 3rd quarter. Royce & Associates LP now owns 38,611 shares of the company’s stock worth $7,389,000 after acquiring an additional 9,152 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.